| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-90705-50ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-89235-50ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-89478-50ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-89267-50ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-90536-50ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-89195-50ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-06616-50ul | |||
![Immunohistochemistry-Paraffin: CD79B Antibody (003) [NBP2-90705] - Immunochemical staining of mouse CD79B in mouse small intestine with rabbit monoclonal antibody at 1:500 dilution, formalin-fixed paraffin embedded sections.](http://images.novusbio.com/fullsize/CD79B-Antibody-003-Immunohistochemistry-Paraffin-NBP2-90705-img0002.jpg "Immunohistochemistry-Paraffin: CD79B Antibody (003) [NBP2-90705] - Immunochemical staining of mouse CD79B in mouse small intestine with rabbit monoclonal antibody at 1:500 dilution, formalin-fixed paraffin embedded sections.")
![Immunohistochemistry-Paraffin: CD79B Antibody (003) [NBP2-90705] - Immunochemical staining of mouse CD79B in mouse spleen with rabbit monoclonal antibody at 1:200 dilution, formalin-fixed paraffin embedded sections.](http://images.novusbio.com/fullsize/CD79B-Antibody-003-Immunohistochemistry-Paraffin-NBP2-90705-img0001.jpg)
![Immunohistochemistry-Paraffin: CCR1 Antibody (003) [NBP2-89235] - Staining of human CCR1 in human tonsil with rabbit monoclonal antibody (1:500).](http://images.novusbio.com/fullsize/CCR1-Antibody-003-Immunohistochemistry-Paraffin-NBP2-89235-img0002.jpg "Immunohistochemistry-Paraffin: CCR1 Antibody (003) [NBP2-89235] - Staining of human CCR1 in human tonsil with rabbit monoclonal antibody (1:500).")
![Immunohistochemistry-Paraffin: CCR1 Antibody (003) [NBP2-89235] - Staining of human CCR1 in human spleen with rabbit monoclonal antibody (1:500).](http://images.novusbio.com/fullsize/CCR1-Antibody-003-Immunohistochemistry-Paraffin-NBP2-89235-img0001.jpg)
![Western Blot: TRAF-3 Antibody (PSH01-30) [NBP3-33042] - Western blot analysis of TRAF-3 on different lysates with Rabbit anti-TRAF-3 antibody (NBP3-33042) at 1/1,000 dilution. Lane 1: TF-1 cell lysate (20 ug/Lane) Lane 2: THP-1 cell lysate (20 ug/Lane) Lane 3: 293T cell lysate (20 ug/Lane) Lane 4: Jurkat cell lysate (20 ug/Lane) Lane 5: A549 cell lysate (20 ug/Lane) Lane 6: RAW264.7 cell lysate (20 ug/Lane) Lane 7: NIH/3T3 cell lysate (20 ug/Lane) Lane 8: Mouse brain tissue lysate (40 ug/Lane) Lane 9: Rat spleen tissue lysate (40 ug/Lane) Lysates/proteins at 10 ug/Lane. Predicted band size: 64 kDa Observed band size: 50 kDa Exposure time: 1 minute 9 seconds; 4-20% SDS-PAGE gel. Proteins were transferred to a PVDF membrane and blocked with 5% NFDM/TBST for 1 hour at room temperature. The primary antibody (NBP3-33042) at 1/1,000 dilution was used in 5% NFDM/TBST at room temperature for 2 hours. Goat Anti-Rabbit IgG - HRP Secondary Antibody at 1:50,000 dilution was used for 1 hour at room temperature.](http://images.novusbio.com/fullsize/nbp3-33042_rabbit-traf-3-mab-psh01-30-288202412493419.jpg "Western Blot: TRAF-3 Antibody (PSH01-30) [NBP3-33042] - Western blot analysis of TRAF-3 on different lysates with Rabbit anti-TRAF-3 antibody (NBP3-33042) at 1/1,000 dilution. Lane 1: TF-1 cell lysate (20 ug/Lane) Lane 2: THP-1 cell lysate (20 ug/Lane) Lane 3: 293T cell lysate (20 ug/Lane) Lane 4: Jurkat cell lysate (20 ug/Lane) Lane 5: A549 cell lysate (20 ug/Lane) Lane 6: RAW264.7 cell lysate (20 ug/Lane) Lane 7: NIH/3T3 cell lysate (20 ug/Lane) Lane 8: Mouse brain tissue lysate (40 ug/Lane) Lane 9: Rat spleen tissue lysate (40 ug/Lane) Lysates/proteins at 10 ug/Lane. Predicted band size: 64 kDa Observed band size: 50 kDa Exposure time: 1 minute 9 seconds; 4-20% SDS-PAGE gel. Proteins were transferred to a PVDF membrane and blocked with 5% NFDM/TBST for 1 hour at room temperature. The primary antibody (NBP3-33042) at 1/1,000 dilution was used in 5% NFDM/TBST at room temperature for 2 hours. Goat Anti-Rabbit IgG - HRP Secondary Antibody at 1:50,000 dilution was used for 1 hour at room temperature.")
![Immunohistochemistry-Paraffin: TRAILR4/TNFRSF10D/DcR2 Antibody (009) [NBP2-89478] - Staining of human TNFRSF10D in human kidney with rabbit monoclonal antibody (1:200). Positive staining was localized to kidney tubules and colleting duct.](http://images.novusbio.com/fullsize/TRAILR4-TNFRSF10D-DcR2-Antibody-009-Immunohistochemistry-Paraffin-NBP2-89478-img0002.jpg "Immunohistochemistry-Paraffin: TRAILR4/TNFRSF10D/DcR2 Antibody (009) [NBP2-89478] - Staining of human TNFRSF10D in human kidney with rabbit monoclonal antibody (1:200). Positive staining was localized to kidney tubules and colleting duct.")
![Immunohistochemistry-Paraffin: TRAILR4/TNFRSF10D/DcR2 Antibody (009) [NBP2-89478] - Staining of human TNFRSF10D in human placenta with rabbit monoclonal antibody (1:200). Positive staining was localized to trophocyte.](http://images.novusbio.com/fullsize/TRAILR4-TNFRSF10D-DcR2-Antibody-009-Immunohistochemistry-Paraffin-NBP2-89478-img0001.jpg)
![Western Blot: CD84/SLAMF5 Antibody (6) [NBP2-89267] - Lane A: RAW264.7 Whole Cell Lysate Lysates/proteins at 30 ug per lane.Secondary Goat Anti-Rabbit IgG H&L (Dylight800) at 1/10000 dilution.Developed using the Odyssey technique. Performed under reducing conditions.Predicted band size:39 kDa Observed band size:39 kDa](http://images.novusbio.com/fullsize/CD84-SLAMF5-Antibody-6-Western-Blot-NBP2-89267-img0002.jpg "Western Blot: CD84/SLAMF5 Antibody (6) [NBP2-89267] - Lane A: RAW264.7 Whole Cell Lysate Lysates/proteins at 30 ug per lane.Secondary Goat Anti-Rabbit IgG H&L (Dylight800) at 1/10000 dilution.Developed using the Odyssey technique. Performed under reducing conditions.Predicted band size:39 kDa Observed band size:39 kDa")
![Immunoprecipitation: CD84/SLAMF5 Antibody (6) [NBP2-89267] - Lane A:0.5 mg Raw264.7 Whole Cell Lysate 0.5 uL anti-CD84 rabbit monoclonal antibody and 15 ul of 50 % Protein G agarose. Primary antibody: Anti-CD84 rabbit monoclonal antibody,at 1:500 dilution Secondary antibody: Dylight 800-labeled antibody to rabbit IgG (H+L), at 1:5000 dilution Developed using the odssey technique. Performed under reducing conditions. Predicted band size: 62 kDaObserved band size: 62 kDa](http://images.novusbio.com/fullsize/CD84-SLAMF5-Antibody-6-Immunoprecipitation-NBP2-89267-img0001.jpg)
![Western Blot: Fc gamma RIII (CD16) Antibody (015) [NBP2-90536] - Anti-Fc gamma RIII (CD16) rabbit monoclonal antibody at 1:500 dilution. Lane A: C6 Whole Cell Lysate. Lysates/proteins at 30 ug per lane. Secondary Goat Anti-Rabbit IgG H&L (Dylight 800) at 1/10000 dilution. Developed using the Odyssey technique. Performed under reducing conditions. Predicted band size: 29 kDa. Observed band size: 38 kDa (We are unsure as to the identity of these extra bands).](http://images.novusbio.com/fullsize/Fc-gamma-RIII-CD16-Antibody-015-Western-Blot-NBP2-90536-img0003.jpg "Western Blot: Fc gamma RIII (CD16) Antibody (015) [NBP2-90536] - Anti-Fc gamma RIII (CD16) rabbit monoclonal antibody at 1:500 dilution. Lane A: C6 Whole Cell Lysate. Lysates/proteins at 30 ug per lane. Secondary Goat Anti-Rabbit IgG H&L (Dylight 800) at 1/10000 dilution. Developed using the Odyssey technique. Performed under reducing conditions. Predicted band size: 29 kDa. Observed band size: 38 kDa (We are unsure as to the identity of these extra bands).")
![Immunoprecipitation: Fc gamma RIII (CD16) Antibody (015) [NBP2-90536] - Fc gamma RIII (CD16) was immunoprecipitated using: Lane A: 0.5 mg RAW246.7 Whole Cell Lysate. 4ul anti-Fc gamma RIII (CD16) rabbit monoclonal antibody and 60 ug of Immunomagnetic beads. Protein A/G. Primary antibody: Anti-Fc gamma RIII (CD16) rabbit monoclonal antibody, at 1:100 dilution. Secondary antibody: Clean-Blot IP Detection Reagent (HRP) at 1:1000 dilution. Developed using the ECL technique. Performed under reducing conditions. Predicted band size: 29 kDa. Observed band size: 50 kDax](http://images.novusbio.com/fullsize/Fc-gamma-RIII-CD16-Antibody-015-Immunoprecipitation-NBP2-90536-img0004.jpg)
![Flow (Cell Surface): CD109 Antibody (W7C5) [NBP2-75969] - Separation of human monocytes (red-filled) from CD109 negative lymphocytes (black-dashed) in flow cytometry analysis (surface staining) of human peripheral whole blood stained using anti-human CD109 (W7C5) purified antibody (concentration in sample 1 ug/ml) GAM APC.](http://images.novusbio.com/fullsize/CD109-Antibody-W7C5-Flow-Cell-Surface-NBP2-75969-img0004.jpg "Flow (Cell Surface): CD109 Antibody (W7C5) [NBP2-75969] - Separation of human monocytes (red-filled) from CD109 negative lymphocytes (black-dashed) in flow cytometry analysis (surface staining) of human peripheral whole blood stained using anti-human CD109 (W7C5) purified antibody (concentration in sample 1 ug/ml) GAM APC.")
![Flow (Cell Surface): CD109 Antibody (W7C5) [NBP2-75969] - Staining pattern of human peripheral blood stained using anti-human CD109 (W7C5) purified antibody (concentration in sample 1 ug/ml) GAM APC.](http://images.novusbio.com/fullsize/CD109-Antibody-W7C5-Flow-Cell-Surface-NBP2-75969-img0003.jpg)
![Flow Cytometry: HLA-E Antibody (3D12) [NBP2-76812] - Separation of human lymphocytes (red-filled) from blood debris (black-dashed) in flow cytometry analysis (surface staining) of human peripheral whole blood stained using HLA-E Antibody (concentration in sample 4 ug/ml) GAM APC.](http://images.novusbio.com/fullsize/HLA-E-Antibody-3D12-Flow-Cytometry-NBP2-76812-img0002.jpg "Flow Cytometry: HLA-E Antibody (3D12) [NBP2-76812] - Separation of human lymphocytes (red-filled) from blood debris (black-dashed) in flow cytometry analysis (surface staining) of human peripheral whole blood stained using HLA-E Antibody (concentration in sample 4 ug/ml) GAM APC.")
![Flow Cytometry: HLA-E Antibody (3D12) [NBP2-76812] - Flow cytometry surface staining pattern of human peripheral blood stained using HLA-E Antibody (concentration in sample 4 ug/ml) GAM APC.](http://images.novusbio.com/fullsize/HLA-E-Antibody-3D12-Flow-Cytometry-NBP2-76812-img0001.jpg)
![Immunohistochemistry-Paraffin: Histamine H1R Antibody [NBP3-14373] - Immunohistochemistry of formalin-fixed, paraffin-embedded human tonsil after heat-induced antigen retrieval. Antibody dilution 4 ug/ml](http://images.novusbio.com/fullsize/Histamine-H1R-Antibody-Immunohistochemistry-Paraffin-NBP3-14373-img0001.jpg "Immunohistochemistry-Paraffin: Histamine H1R Antibody [NBP3-14373] - Immunohistochemistry of formalin-fixed, paraffin-embedded human tonsil after heat-induced antigen retrieval. Antibody dilution 4 ug/ml")
![Immunohistochemistry-Paraffin: Histamine H1R Antibody [NBP3-14373] - Immunohistochemistry of formalin-fixed, paraffin-embedded human spleen after heat-induced antigen retrieval. Antibody dilution 4 ug/ml](http://images.novusbio.com/fullsize/Histamine H1R Antibody-Immunohistochemistry-Paraffin-NBP3-14373-img0002.jpg)
![Immunohistochemistry-Paraffin: IL-1ra/IL-1F3/IL1RN Antibody (005) [NBP2-89195] - Staining of human IL1RA in human kidney with rabbit monoclonal antibody (1:100).](http://images.novusbio.com/fullsize/IL-1ra-IL-1F3-IL1RN-Antibody-005-Immunohistochemistry-Paraffin-NBP2-89195-img0002.jpg "Immunohistochemistry-Paraffin: IL-1ra/IL-1F3/IL1RN Antibody (005) [NBP2-89195] - Staining of human IL1RA in human kidney with rabbit monoclonal antibody (1:100).")
![Immunohistochemistry-Paraffin: IL-1ra/IL-1F3/IL1RN Antibody (005) [NBP2-89195] - Staining of human IL1RA in human skin with rabbit monoclonal antibody (1:100).](http://images.novusbio.com/fullsize/IL-1ra-IL-1F3-IL1RN-Antibody-005-Immunohistochemistry-Paraffin-NBP2-89195-img0001.jpg)
![Flow Cytometry: ITCH/AIP4 Antibody (01) [NBP3-06616] - Analysis of Human ITCH expression on HeLa cells. The cells were treated, stained with purified anti-Human ITCH, then a FITC-conjugated second step antibody. The fluorescence histograms were derived from gated events with the forward and side light-scatter characteristics of intact cells.](http://images.novusbio.com/fullsize/ITCH-AIP4-Antibody-01-Flow-Cytometry-NBP3-06616-img0002.jpg "<b>Biological Strategies Validation. </b>Flow Cytometry: ITCH/AIP4 Antibody (01) [NBP3-06616] - Analysis of Human ITCH expression on HeLa cells. The cells were treated, stained with purified anti-Human ITCH, then a FITC-conjugated second step antibody. The fluorescence histograms were derived from gated events with the forward and side light-scatter characteristics of intact cells.")
![<b>Biological Strategies Validation. </b>Immunocytochemistry/Immunofluorescence: ITCH/AIP4 Antibody (01) [NBP3-06616] - Staining of Human ITCH in Hela cells. Cells were fixed with 4% PFA, permeabilzed with 1% Triton X-100 in PBS, blocked with 10% serum, and incubated with NBP3-06616 antibody (1:60) at 37? 1 hour. Then cells were stained with the Alexa Fluor 488-conjugated Goat Anti-mouse IgG secondary antibody (green) and counterstained with DAPI (blue). Positive staining was localized to cytoplasm.](http://images.novusbio.com/fullsize/nbp3-06616_mouse-monoclonal-itch-aip4-antibody-01-23520251433151.png)